Abstract

Extracorporeal Membrane Oxygenation (ECMO) is a resource intensive, life-preserving support system that has seen ever-expanding clinical indications as technology and collective experience has matured. Clinicians caring for patients who develop pulmonary failure secondary to cardiac failure can find themselves in unique situations where traditional ECMO may not be the ideal clinical solution. Existing paracorporeal ventricular assist device (VAD) technology or unique patient physiologies offer the opportunity for thinking “outside the box.” Hybrid ECMO approaches include splicing oxygenators into paracorporeal VAD systems and alternative cannulation strategies to provide a staged approach to transition a patient from ECMO to a VAD. Alternative technologies include the adaptation of ECMO and extracorporeal CO2 removal systems for specific physiologies and pediatric aged patients. This chapter will focus on: (1) hybrid and alternative approaches to extracorporeal support for pulmonary failure, (2) patient selection and, (3) technical considerations of these therapies. By examining the successes and challenges of the relatively select patients treated with these approaches, we hope to spur appropriate research and development to expand the clinical armamentarium of extracorporeal technology.

Highlights

  • For the past 40 years, pediatric extracorporeal life support (ECLS) has utilized innovative strategies, novel technology, or repurposed adult medical devices to provide life-saving care to this unique patient population

  • Unfractionated heparin was administered with a target ACT of 160–200 s and antithrombin replacement to maintain levels greater than 80%

  • Anecdotes of these off-label applications of extracorporeal membrane oxygenation (ECMO) and ventricular assist device (VAD) technology from the field indicate that additional paracorporeal oxygenator support with or without a paracorporeal VAD can be accomplished by experienced practitioners

Read more

Summary

INTRODUCTION

For the past 40 years, pediatric extracorporeal life support (ECLS) has utilized innovative strategies, novel technology, or repurposed adult medical devices to provide life-saving care to this unique patient population. In 2017, Monge et al reported a small case series utilizing an adult paracorporeal continuous-flow VAD (Tandem Heart, Cardiac Assist, Pittsburgh, USA) in 13 pediatric patients (0.4– 2.1 m2 BSA), including three patients with single ventricle physiology [20, 38]. All patients had their left atrium (or common atrium for single ventricles) cannulated using a standard metal-tip right-angle bypass cannula. This is a similar approach to the design of the CardioHelp R (Maquet), which was designed as a more self-contained, cartridge style, rapidly deployable ECMO system

CONCLUSIONS
ECLS Registry Report
Findings
35. The Penn State Heart Pump
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call